Question 1

Does Renaissance Technologies own TRDA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Renaissance Technologies holds 191,000 shares of TRDA (Entrada Therapeutics), worth $1.4M.

Question 2

How many shares of TRDA does Renaissance Technologies own?

Accepted Answer

As of its Q2 2026 13F, Renaissance Technologies holds 191,000 shares of TRDA (Entrada Therapeutics).

Question 3

What is Renaissance Technologies' TRDA position worth?

Accepted Answer

As of its Q2 2026 13F, Renaissance Technologies' TRDA position is worth $1.4M.

Question 4

Is Renaissance Technologies buying or selling TRDA?

Accepted Answer

In Q2 2026, Renaissance Technologies reduced its TRDA position by 11,084 shares (-5.5%).

Question 5

When did Renaissance Technologies first buy TRDA?

Accepted Answer

Renaissance Technologies already held TRDA in its Q4 2021 13F, the earliest on record, and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	191,000	-5.5%	$1.4M	0.0%	$7.36	0
2026-Q1	Decreased	202,084	-20.0%	$2.6M	0.0%	$11.85	0
2025-Q4	Decreased	252,635	-57.5%	$2.6M	0.0%	$10.09	0
2025-Q3	Increased	594,300	+56.6%	$3.4M	0.0%	$5.84	38
2025-Q2	Increased	379,500	+15.5%	$2.6M	0.0%	$6.91	30
2025-Q1	Increased	328,485	+97.6%	$3M	0.0%	$9.56	42
2024-Q4	Increased	166,200	+77.2%	$2.9M	0.0%	$17.37	40
2024-Q3	Increased	93,800	+110.3%	$1.5M	0.0%	$16.45	41

TRDAShowing 8 of 12 quarters

TRDA
Showing 8 of 12 quarters